People

Michelle Zheng

Michelle Zheng (Michelle Zheng) is published in Korea Investment Partners’ current China Partners directory as Associate Partner. Michelle is Associate Partner at KIP's Shanghai office. Prior to joining KIP, she worked at Fosun Pharma, Newmargin Capital, and Ipsos Group S.A., building experience across corporate strategy consulting, venture capital, and the biotech sector. She graduated from NUS (National University of Singapore) with an MBA and from Shanghai University with a Bachelor's degree in Business Management. She focuses on early-to-growth-stage tech and hard-tech investments (Series A–C). She believes technology must translate into validated applications and tangible customer value, favoring companies with strong R&D, clear commercial paths, and robust execution. Published education: B.B.M., Business Management, Shanghai University M.B.A., Concordia University. The primary profile’s career/background list names Fosun Pharma, New Margin, IPSOS; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.